Market Research Report
Global Biodefense Market 2019-2025
|Published by||Orion Market Research Pvt Ltd||Product code||869635|
Delivery time: 2-3 business days
|Global Biodefense Market 2019-2025|
|Published: May 31, 2019||Content info:||
Global Biodefense Market Size, Share & Trends Analysis Report by Biological Threat (Anthrax, Small-Pox, Radiation and Others), and by Product (Immunization vaccine, Antibiotics, Masks and Others) and Forecast, 2019-2025
A biological threat agent is a bacteria, virus, or a fungus that can be deliberately used as a weapon in bioterrorism. Biodefense is the method of taking precaution and protection against biological threat. There is a high growth opportunity in this market due to the rising government funding for countermeasure against biothreats. Additionally, increasing prevalence of infectious diseases such as influenza along with increasing research and development investment on the vaccine and other antibiotics is driving the growth of the market. However, stringent government regulation and lack of awareness are some of the restraint to the growth of biodefense market.
The global biodefense market is segmented on the basis of biological threat and product. On the basis of product, the market is further segmented into immunization vaccine, antibiotics, masks and others. Among these, the immunization vaccine segment is expected to have considerable market share due high prevalence of infectious diseases and rising focus on immunization programs.9 On the basis of biological threat, the market is further classified into anthrax, small-pox, radiation and others.
The global biodefense market is segmented on the basis of regions includes North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is expected to have significant share in the global biodefense market owing to increasing FDA approval and presence of robust pipeline. For instance, US FDA has licensed several vaccines to prevent infections, such as Emergent BioSolutions Inc., US received FDA approval for BioThrax for the prevention of anthrax. Asia-Pacific is considered to witness the significant market growth in the global biodefense market during the forecast period. Rising government initiatives against bioterrorism in various countries such as China, India, and Japan is one of the factorsdriving the biodefense market growth in this region. Key vendors operating in the global biodefense market are Emergent BioSolutions, Inc., SIGA Technologies, Inc., Elusys Therapeutics, Dynavax Technologies Corp.. Partnership & collaborations, merger & acquisition are some of the strategies these companies are adopting in order to stay competitive in the market. For instance, in December 2016, Emergent BioSolutions entered into a contract with the CDC. The deal was signed at $911 million for the supply of over 29 million BioThrax anthrax vaccine that is to be provided over five years.
The market study of the global biodefense market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behaviour and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
The report is intended for research organizations, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
5.1.4 Others (E-Bola, Zika, Botulism)